Linden Thomas Advisory Services’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Buy
3,981
+48
+1% +$7.12K 0.06% 375
2026
Q1
$366K Buy
3,933
+57
+1% +$5.05K 0.04% 407
2025
Q4
$311K Sell
3,876
-209
-5% -$17.5K 0.03% 425
2025
Q3
$399K Sell
4,085
-42
-1% -$3.38K 0.04% 398
2025
Q2
$288K Buy
+4,127
New +$235K 0.03% 409
2024
Q3
Sell
-1,766
Closed -$251K 466
2024
Q2
$251K Buy
+1,766
New +$204K 0.04% 414
2024
Q1
Sell
-1,656
Closed -$215K 454
2023
Q4
$215K Buy
+1,656
New +$228K 0.04% 401

Other funds holding ACLS

Linden Thomas Advisory Services's ACLS Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Axcelis (ACLS) stake by 1.2% in Q2 2026, buying an estimated $7.12K and bringing the position to 3,981 shares worth $754K. The position accounts for 0.06% of the portfolio, ranked #375.

Linden Thomas Advisory Services first reported a position in ACLS in Q4 2023 and has held it in 7 quarters since. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Linden Thomas Advisory Services held 3,981 shares of Axcelis worth $754K as of Q2 2026.
  • Linden Thomas Advisory Services bought 48 Axcelis shares in Q2 2026, an estimated $7.12K.
  • Axcelis made up 0.06% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #375 holding.
  • Linden Thomas Advisory Services first reported a position in Axcelis in Q4 2023 and has held it in 7 quarters since.
  • 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.